HFMA

Cost Effectiveness of Health Report, December 2021

The December HFMA’s Cost Effectiveness of Health Report, sponsored by Kaufman Hall, leads off with the fourth and final report for 2021 in HFMA’s Healthcare 2030 series, focused on the long-term direction of strategic investment for hospitals and health systems. Also included are an article describing a new “employer-friendly” model of center of excellence and a commentary on how the FDA’s accelerated approval process may unintentionally be increasing the nation’s drug expense.

Payvider Survey Summary Report

HFMA, with sponsorship from Guidehouse, surveyed over 100 health system CFOs and finance and managed care executives to understand payvider model trends. The survey indicates that provider organizations are gravitating towards risk-based payment models. Nearly 60% of health systems responding to the survey plan to advance into risk-based Medicare Advantage models this year. Survey respondents…

No Surprises Act inspires short-term and long-term operational areas of focus

The rush may be over, but the race has just begun. After sprinting to implement the requirements of the No Surprises Act by the Jan. 1, 2022, deadline, providers must now shift attention to refining their processes for what lies ahead. Assuming familiarity with the law’s key requirements, providers and facilities are focused on the…

04

03

02

01

Revenue cycle innovation: How automation can mitigate the financial impact of COVID-19

These four tips will help hospital financial leaders lessen the economic impact of COVID-19 now and in the future: Build and retain a core revenue cycle team, contain labor costs, redeploy talent more effectively and enhance revenue integrity.

December 2021

December 2021 issue of hfm on innovation and disruption

Exploring opportunities to improve provider-payer data exchange

Revenue cycle leaders share strategies and the benefits for effective data exchange between providers and payers, as well as the challenges in this executive roundtable.